# Methamphetamine and Methamphetamine-Induced Neuronal Exosomes Modulate the Activity of Rab7a via PTEN to Exert an Influence on the Disordered Autophagic Flux Induced in Neurons

**Authors:** Hai Qiu, Manting Zhang, Minchun Li, Chuanxiang Chen, Huijun Wang, Xia Yue

PMC · DOI: 10.3390/ijms26062644 · International Journal of Molecular Sciences · 2025-03-14

## TL;DR

Methamphetamine disrupts autophagy in neurons by altering Rab7a activity through PTEN, leading to autophagosome accumulation and neuronal damage.

## Contribution

This study reveals that METH-induced exosomes modulate Rab7a via PTEN to impair autophagic flux in neurons.

## Key findings

- METH treatment increases autophagosome accumulation in neurons and SH-SY5Y cells.
- METH reduces Rab7a dephosphorylation by downregulating PTEN, impairing autophagosome-lysosome fusion.
- METH-induced exosomes alter miRNA profiles, further reducing PTEN and exacerbating autophagic flux impairment.

## Abstract

Autophagy is a critical mechanism by which methamphetamine (METH) induces neuronal damage and neurotoxicity. Prolonged METH exposure can result in the accumulation of autophagosomes within cells. The autophagy process encompasses several essential vesicle-related biological steps, collectively referred to as the autophagic flux. However, the precise mechanisms by which METH modulates the autophagic flux and the underlying pathways remain to be elucidated. In this study, we utilized a chronic METH exposure mouse model and cell model to demonstrate that METH treatment leads to an increase in p62 and LC3B-II and the accumulation of autophagosomes in striatal neurons and SH-SY5Y cells. To assess autophagic flux, this study utilized autophagy inhibitors and inducers. The results demonstrated that the lysosomal inhibitor chloroquine exacerbated autophagosome accumulation; however, blocking autophagosome formation with 3-methyladenine did not prevent METH-induced autophagosome accumulation. Compared to the autophagy activator rapamycin, METH significantly reduced autophagosome–lysosome fusion, leading to autophagosome accumulation. Rab7a is a critical regulator of autophagosome–lysosome fusion. Although Rab7a expression was upregulated in SH-SY5Y cells and brain tissues after METH treatment, immunoprecipitation experiments revealed weakened interactions between Rab7a and the lysosomal protein RILP. Overexpression of active Rab7a (Rab7a Q67L) significantly alleviated the METH-induced upregulation of LC3-II and p62. PTEN, a key regulator of Rab7a dephosphorylation, was downregulated following METH treatment, resulting in decreased Rab7a dephosphorylation and reduced Rab7a activity, thereby contributing to autophagosome accumulation. We further investigated the role of neuronal exosomes in the autophagy process. Our results demonstrated that the miRNA expression profiles in exosomes released by METH-induced SH-SY5Y cells were significantly altered, with 122 miRNAs upregulated and 151 miRNAs downregulated. KEGG and GO enrichment analyses of these differentially expressed miRNAs and their target genes revealed significant associations with the autophagy pathway and potential regulation of PTEN expression. Our experiments confirmed that METH-induced exosomes reduced PTEN expression levels and decreased Rab7a dephosphorylation, thereby exacerbating autophagic flux impairment and autophagosome accumulation. In conclusion, our study indicated that METH and its induced neuronal exosomes downregulate PTEN expression, leading to reduced Rab7a dephosphorylation. This, in turn, hinders the fusion of autophagosomes and lysosomes, ultimately resulting in autophagic flux impairment and neuronal damage.

## Linked entities

- **Genes:** RAB7A (RAB7A, member RAS oncogene family) [NCBI Gene 7879], PTEN (phosphatase and tensin homolog) [NCBI Gene 5728], GTF2H1 (general transcription factor IIH subunit 1) [NCBI Gene 2965], MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631], RILP (Rab interacting lysosomal protein) [NCBI Gene 83547]
- **Proteins:** RAB7A (RAB7A, member RAS oncogene family), PTEN (phosphatase and tensin homolog), GTF2H1 (general transcription factor IIH subunit 1), RILP (Rab interacting lysosomal protein)
- **Chemicals:** methamphetamine (PubChem CID 1206), chloroquine (PubChem CID 2719), 3-methyladenine (PubChem CID 135398661), rapamycin (PubChem CID 5284616)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, RAB7A (RAB7A, member RAS oncogene family) [NCBI Gene 7879] {aka CMT2B, PRO2706, RAB7}, RILP (Rab interacting lysosomal protein) [NCBI Gene 83547] {aka PP10141}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}
- **Diseases:** neuronal damage (MESH:D009410), neurotoxicity (MESH:D020258)
- **Chemicals:** 3-methyladenine (MESH:C025946), chloroquine (MESH:D002738), METH (MESH:D008694), rapamycin (MESH:D020123)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** Q67L
- **Cell lines:** SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11941945/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11941945/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC11941945/full.md

---
Source: https://tomesphere.com/paper/PMC11941945